Full Length Article
Protonation of curcumin triggers sequential double cyclization in the gas-phase: An electrospray mass spectrometry and DFT study

https://doi.org/10.1016/j.ijms.2019.01.002Get rights and content

Highlights

  • Rearrangement of protonated curcumin characterized by mass spectrometry and DFT.

  • Protonated curcumin undergoes two consecutive cyclization reactions in the gas phase.

  • The precursor upon protonation undergoes competitive eliminations of 2-methoxy phenol and C4H4O2, presumably diketene.

  • This gas-phase rearrangement may be predictive of solution chemistry and be predictive for biological function.

Abstract

ESI-protonated natural curcumin (1) undergoes gas-phase cyclization and dissociates via competitive expulsions of 2-methoxy phenol and C4H4O2 (diketene or an isomer). Evidence from mechanistic mass spectrometry and from Density Functional Theory (DFT) reveals that a two-step sequential cyclization occurs for the protonated molecule prior to the unusual loss of the elements of 2-methoxy phenol. Furthermore, the presence of the methoxy group at postion-3 is essential for the second cyclization. The transformation of curcumin upon protonation in the gas phase may be predictive of its solution chemistry and explain how curcumin plays a protective role in biology.

Introduction

Curcumin is a yellow, polyphenolic pigment isolated from the rhizomes of the spice turmeric (Curcuma longa). Curcumin exhibits a variety of biological activities including those of an antioxidant, anticancer compound, and a mediator in Aβ amyloid formation with important implications in Alzheimer’s disease [[1], [2], [3], [4], [5]]. The mechanism of antioxidant activity of this 1,3-diketone (I), containing two phenolic OH groups and two double bonds, has been the subject of many experimental [[6], [7], [8], [9]] and theoretical investigations [10,11]. To determine the relationship between the structure and antioxidant activity of curcumin, investigators have focused on the role of the phenolic-OH group, the enol-OH group, and double bond [12]. The instability of curcumin under biological pH conditions [13] has led to the hypothesis that its degradation products [14] and metabolites [15,16] may be the means whereby curcumin exhibits its biological activity. The bio-transformations of curcumin, although not fully understood, may produce metabolites including dihydrocurcumin and tetrahydrocurcumin that are biologically active [17]. Additional transformation products of autoxidation and double cyclization of curcumin are known and likely to contribute to its pharmacological activities [18].

The consumption of turmeric seems to reduce the risk of some cancers and provide salutary biological effects that correlate with curcumin content [19]. Of the three analogs present in Curcuma longa, curcumin (1) is the most biologically active component compared to the demethoxy- (2) and bisdemethoxy analogs [20,21]. It is essential to understand the possible acid-catalyzed rearrangements of curcumin given that the digestive juices of the stomach are at low pH. Moreover, the capability of curcumin to serve as an antioxidant is high [2] at low pH, suggesting a role for protonation of the molecule in its biological chemistry. Determining the outcome of protonation is an opportunity for electrospray ionization and mass spectrometry, which can bring a deeper understanding of this biologically important food substance and supplement.

Electrospray ionization (ESI) generates protonated/deprotonated molecules and introduces them to the gas-phase. The unimolecular transformations of both [M + H]+ and [M − H] ions and the mechanism of these reactions have been studied by various experimental approaches, including tandem mass spectrometry and DFT calculations In fact, acid-catalyzed transformations of organic molecules in solution can be predicted on the basis of mass spectrometric fragmentations of protonated molecules [22,23]. The use of mass spectrometer for studying various chemical reactions has led to the suggestion that it is “complete chemical laboratory” [24]. Related studies carried out in our laboratory are of 2-methoxychalcone [25], N-(2-nitrophenyl)alanine [26] and bis-(2-methoxybenzal)acetone [27], and these investigations demonstrate that unimolecular cyclization reactions upon ESI protonation have counterparts in solution and suggest that ESI MS in combination with DFT is an effective approach for predicting acid-catalyzed cyclizations of organic molecules in solution.

We report here an investigation of the possible rearrangements of protonated curcumin (1), mono-methoxycurcumin (2), and the synthetic analogs 3 and 4 by ESI mass spectrometry and DFT calculations. Our hypothesis is that any rearrangement occurring in the mass spectrometer also occurs in solution and provides insight on the biological activity of curcumin. LC/MS [28] and NMR [29] already show that natural curcumin containing a 1,3-diketone with conjugated double bonds, exists as a stable enol. The enol form of curcumin, upon protonation, may undergo cyclization analogous to a Nazarov reaction [30]. The collisionally-activated decomposition (CAD) product-ion mass spectrum of ESI-produced curcumin was reported previously, but without any supporting theoretical calculations [31], and the proposed mechanisms involved forbidden and other high-energy processes. There are no reports regarding a solution rearrangement of curcumin under acidic conditions although the oxidative cyclizations of curcumin [18] and mono-methoxycurcumin [14] in buffer solutions at pH 7.4 were noted.

Section snippets

Synthesis

Natural curcumin (1) and mono-methl-oxy curcumin (2) were extracted from turmeric powder using acetone and purified by column chromatography on silica gel using (1:1) mixture of ethyl acetate and hexane as the eluent. Compounds 3 and 4 were synthesized from acetylacetone and the appropriate benzaldehyde by employing literature procedures [32]. The structures of the compounds were confirmed by 1HNMR spectrometry and accurate-mass MS data.

Mass spectrometry

Formation of the positive-ion precursors, via protonation,

Mass spectrometry

The CAD spectrum of the [M + H]+ ion of curcumin 1, m/z 369, shows major fragment ions of m/z 299, 285, 259 and 245, the latter being most abundant, arising from eliminations of 70, 84, 110 and 124 u (Fig. 1), respectively. The measured accurate masses of the product ions (Table 1) revealed that the ions of m/z 299, 285, and 245 are formed by the eliminations of neutral species corresponding to C3H2O2 (possibly CH2CO + CO, 70 u), C4H4O2 (possibly 2x CH2CO, 84 u), C6H6O2, and C7H8O2 (the

Conclusions

The most abundant product ion (of m/z 245) in the CAD mass spectrum of protonated curcumin occurs by the elimination of 2-methoxy phenol. Intrigued by this interesting rearrangement and fragmentation, we used mass spectrometry and DFT calculations to show that the elimination of 2-methoxy phenol occurs following two consecutive cyclizations of protonated curcumin. The isomerization/cyclization of protonated curcumin, a strong antioxidant, may be biologically relevant and account for the

Acknowledgements

The authors JC, JP and MG thank Principal, S.H. College, and Thevara, Cochin for providing infrastructure. RS thank Director IICT, Hyderabad, for providing the mass spectral facility. Research at WU was supported by the National Institute of General Medical Sciences of the NIH, Grant P41GM103422. In addition, this work made use of the Washington University Computational Chemistry Facility, supported by NSF grant CHE-0443501.

References (37)

  • D. Yanagisawa et al.

    Relationship between the tautomeric structures of curcumin derivatives and their Aβ-binding activities in the context of therapies for Alzheimer’s disease

    Biomaterials

    (2010)
  • T. Weiske et al.

    High-energy collision of Kr@C60+. with helium. Evidence for the formation of HeKr@C60+

    Chem. Phys. Lett.

    (1994)
  • J. Wang et al.

    New insights in amyloid Beta interactions with human telomerase

    J. Am. Chem. Soc.

    (2015)
  • P. Malik et al.

    Structure-function elucidation of antioxidative and prooxidative activities of the polyphenolic compound curcumin

    Chin. J. Biol.

    (2014)
  • M. Heger et al.

    The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to Cancer

    Pharmacol. Rev.

    (2013)
  • T. Esatbeyoglu et al.

    Curcumin-from molecule to biological function

    Angew. Chem. Int. Ed.

    (2012)
  • X. Zhang et al.

    Design and synthesis of curcumin analogues for in vivo fluorescence imaging and inhibiting copper-induced cross-linking of amyloid Beta species in alzheimer’s disease

    J. Am. Chem. Soc.

    (2013)
  • K.S. Bhullar et al.

    Curcumin and its carbocyclic analogs: structure-activity in relation to antioxidant and selected biological properties

    Molecules

    (2013)
  • View full text